Key Events This Week
Feb 9: Downgrade to Sell by MarketsMOJO announced
Feb 13: Q3 FY26 results reveal revenue decline but stable margins
Feb 13: Week closes at Rs.115.20 (-1.66%)
Mar 30
BSE+NSE Vol: 9.45 k

For the second consecutive session, Smruthi Organics Ltd has seen its share price decline, hitting a fresh 52-week low of Rs 102 on 30 Mar 2026. This latest drop extends the stock’s recent underperformance despite some positive financial indicators.
Read full news article
Smruthi Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Smruthi Organics Ltd has seen its investment rating downgraded from Hold to Sell as of 6 March 2026, reflecting a shift in technical indicators and concerns over its long-term financial growth. Despite some positive quarterly results and attractive valuation metrics, the company’s overall performance and technical trends have prompted a cautious stance among investors.
Read full news article
Smruthi Organics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 4 March 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but positive outlook for investors.
Read full news article
Smruthi Organics Ltd is rated Sell by MarketsMOJO. This rating was last updated on 06 February 2026, reflecting a change from the previous Hold rating. However, all fundamentals, returns, and financial metrics discussed here are current as of 03 March 2026, providing investors with the latest assessment of the stock’s position.
Read full news article
Smruthi Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Smruthi Organics Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a nuanced change in price appeal within the Pharmaceuticals & Biotechnology sector. Despite recent downward price pressure, the company’s valuation metrics relative to peers and historical averages suggest a recalibration that investors should carefully analyse.
Read full news articleSmruthi Organics Ltd's latest financial results for Q3 FY26 reveal significant revenue and profit challenges, highlighting a concerning trend of volatility in its operational performance. The company reported net sales of ₹22.29 crores, reflecting a substantial decline of 29.46% compared to the previous quarter, following an unusual surge of 66.40% in Q2 FY26. Year-on-year, revenues also contracted by 28.67%, indicating persistent demand challenges in its operating environment. Net profit for the quarter fell to ₹1.40 crores, down 32.04% from ₹2.06 crores in Q2 FY26. This decline in profitability is primarily attributed to the sharp revenue contraction. Despite these challenges, Smruthi Organics managed to expand its operating margin to 17.95%, up from 15.85% in the previous quarter. This improvement suggests effective cost management and operational resilience amidst the pressures on revenue. The financi...
Read full news article